Atorvastatin 20mg Tablets
Overview
What is this medicine?
How to Use This Medicine
To get the most benefit from your medication, follow your doctor's instructions carefully. Read all the information provided with your prescription and follow the instructions closely. You can take this medication with or without food, and it's best to take it at the same time every day.
Continuing Your Treatment
Continue taking this medication as directed by your doctor or healthcare provider, even if you start to feel better. It's essential to complete the full course of treatment as prescribed.
Storing and Disposing of Your Medication
Store your medication at room temperature in a dry place, away from the bathroom. Keep all medications in a safe and secure location, out of the reach of children and pets.
Missing a Dose
If you miss a dose, skip it and take your next dose at the usual time. Do not take two doses at the same time or take extra doses to make up for the missed one.
Lifestyle & Tips
- Maintain a cholesterol-lowering diet (low in saturated and trans fats, cholesterol).
- Engage in regular physical activity as recommended by your doctor.
- Achieve and maintain a healthy weight.
- Quit smoking.
- Limit alcohol intake.
Available Forms & Alternatives
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:
Signs of an allergic reaction: rash, hives, itching, red, swollen, blistered, or peeling skin (with or without fever), wheezing, tightness in the chest or throat, trouble breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat
Signs of a urinary tract infection (UTI): blood in the urine, burning or pain when passing urine, frequent or urgent need to urinate, fever, lower stomach pain, or pelvic pain
Signs of a severe skin reaction (Stevens-Johnson syndrome/toxic epidermal necrolysis): red, swollen, blistered, or peeling skin (with or without fever), red or irritated eyes, or sores in the mouth, throat, nose, or eyes
Severe dizziness or fainting
Rapid heartbeat
Weakness on one side of the body, trouble speaking or thinking, balance problems, drooping on one side of the face, or blurred vision
Difficulty urinating or changes in urine output
Muscle problems: abnormal muscle pain, tenderness, or weakness (with or without fever); if your doctor instructs you to stop the medication but your muscle problems persist, contact your doctor
Liver Problems: A Serious and Potentially Life-Threatening Condition
This medication can cause severe and potentially deadly liver problems. If you experience any of the following symptoms, contact your doctor immediately:
Dark urine
Fatigue
Decreased appetite
Upset stomach or stomach pain
Light-colored stools
Vomiting
Yellow skin or eyes
Other Possible Side Effects
Like all medications, this drug can cause side effects. Many people may not experience any side effects or only minor ones. However, if you notice any of the following side effects or any other symptoms that bother you or do not go away, contact your doctor or seek medical attention:
Diarrhea
Joint pain
Pain in arms or legs
Upset stomach
Nose or throat irritation
Signs of a common cold
Trouble sleeping
Reporting Side Effects
This list is not exhaustive, and you may experience other side effects not mentioned here. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Unexplained muscle pain, tenderness, or weakness (especially if accompanied by fever or dark urine)
- Yellowing of the skin or eyes (jaundice)
- Dark urine
- Severe stomach pain
- Unusual tiredness or weakness
- Loss of appetite
- Nausea or vomiting
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced.
If you have liver disease or elevated liver enzymes.
If you are currently taking any of the following medications: cyclosporine, gemfibrozil, glecaprevir plus pibrentasvir, letermovir, or tipranavir plus ritonavir.
If you are pregnant or think you might be pregnant. Note that this medication should not be taken during pregnancy.
* If you are breastfeeding. You should not breastfeed while taking this medication.
This list is not exhaustive, and it is crucial to discuss all your medications (including prescription, over-the-counter, natural products, and vitamins) and health issues with your doctor and pharmacist. They will help determine if it is safe for you to take this medication alongside your other treatments and health conditions. Never start, stop, or adjust the dosage of any medication without first consulting your doctor.
Precautions & Cautions
To ensure your safety while taking this medication, adhere to the diet and exercise plan recommended by your doctor. If you consume grapefruit juice or eat grapefruit frequently, discuss this with your doctor. It is also important to limit your alcohol intake to no more than 2 drinks per day, as excessive alcohol consumption may increase your risk of developing liver disease.
Be aware that this medication may cause muscle pain, tenderness, or weakness, which can be severe and potentially lead to kidney problems. In rare cases, this has resulted in fatalities. Your risk may be higher if you have pre-existing thyroid problems, kidney problems, infections, low blood pressure, or a history of seizures. Taking certain other medications or being dehydrated may also increase your risk. Furthermore, individuals aged 65 and older may be at a higher risk. If you have any concerns or questions, consult your doctor.
If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects. It is also important to note that this medication may harm an unborn baby. If you are of childbearing age, use effective birth control while taking this medication. If you become pregnant, notify your doctor immediately.
Overdose Information
Overdose Symptoms:
- No specific symptoms of overdose have been reported. The most likely adverse effects would be an exaggeration of known side effects, such as muscle pain or liver enzyme elevations.
What to Do:
There is no specific antidote for atorvastatin overdose. In the event of an overdose, the patient should be treated symptomatically, and supportive measures instituted as required. Hemodialysis is not expected to significantly enhance atorvastatin clearance due to its high protein binding. Call 1-800-222-1222 (Poison Control Center) for advice.
Drug Interactions
Contraindicated Interactions
- Cyclosporine
- Gemfibrozil
- Tipranavir/Ritonavir
- Telaprevir
Major Interactions
- Strong CYP3A4 inhibitors (e.g., Itraconazole, Ketoconazole, Voriconazole, Posaconazole, Clarithromycin, Telithromycin, Nefazodone, HIV protease inhibitors like Ritonavir, Lopinavir/Ritonavir, Saquinavir/Ritonavir, Darunavir/Ritonavir, Fosamprenavir, Fosamprenavir/Ritonavir)
- Niacin (lipid-lowering doses âĨ1 g/day)
- Colchicine
- Fibrates (e.g., Fenofibrate)
Moderate Interactions
- Moderate CYP3A4 inhibitors (e.g., Erythromycin, Diltiazem, Verapamil, Fluconazole)
- Amiodarone
- Grapefruit juice (large quantities >1.2 liters/day)
- Digoxin
- Oral contraceptives (norethindrone, ethinyl estradiol)
Minor Interactions
- Antacids (magnesium and aluminum hydroxides)
- Colestipol
Monitoring
Baseline Monitoring
Rationale: To establish baseline lipid levels and assess treatment efficacy.
Timing: Prior to initiation of therapy.
Rationale: To assess baseline hepatic function and identify pre-existing liver disease.
Timing: Prior to initiation of therapy.
Rationale: To establish baseline in patients at increased risk for myopathy (e.g., renal impairment, hypothyroidism, genetic muscle disorders, prior statin-associated myopathy).
Timing: Prior to initiation of therapy (if indicated).
Routine Monitoring
Frequency: 4-12 weeks after initiation or dose titration, then every 3-12 months
Target: Individualized based on risk assessment and treatment goals (e.g., LDL-C reduction of 30-50% or >50% depending on intensity)
Action Threshold: If lipid goals not met, consider dose titration or alternative therapy. If levels are excessively low, consider dose reduction.
Frequency: Periodically as clinically indicated (e.g., if symptoms of liver injury occur). Routine periodic monitoring is no longer universally recommended unless clinically indicated.
Target: Within normal limits
Action Threshold: If persistent elevations >3 times the upper limit of normal (ULN) occur, discontinue atorvastatin. If elevations are 1-3 times ULN, monitor closely or consider dose reduction/discontinuation.
Frequency: Only if muscle symptoms (pain, tenderness, weakness) develop.
Target: Within normal limits
Action Threshold: If CK levels are significantly elevated (>10 times ULN) or if muscle symptoms are severe, discontinue atorvastatin. If CK is elevated but <10 times ULN and symptoms are mild, monitor closely.
Symptom Monitoring
- Unexplained muscle pain
- Muscle tenderness
- Muscle weakness
- Dark urine (cola-colored)
- Unusual fatigue
- Loss of appetite
- Upper right abdominal pain
- Nausea
- Vomiting
- Yellowing of skin or eyes (jaundice)
Special Patient Groups
Pregnancy
Contraindicated. Atorvastatin may cause fetal harm when administered to a pregnant woman. Cholesterol and other products of cholesterol biosynthesis are essential for fetal development, including synthesis of steroids and cell membranes. The risk of therapy outweighs the benefits.
Trimester-Specific Risks:
Lactation
Contraindicated. Atorvastatin is excreted into breast milk in rats, and it is unknown whether it is excreted in human milk. Due to the potential for serious adverse reactions in nursing infants, women taking atorvastatin should not breastfeed.
Pediatric Use
Approved for use in pediatric patients aged 10-17 years with heterozygous familial hypercholesterolemia. Dosing is typically 10 mg once daily, with a maximum of 20 mg/day. Safety and efficacy in patients younger than 10 years have not been established.
Geriatric Use
No overall differences in safety or effectiveness have been observed between patients âĨ65 years of age and younger patients. However, greater sensitivity of some older individuals cannot be ruled out. No dosage adjustment is necessary based solely on age.
Clinical Information
Clinical Pearls
- Atorvastatin can be taken at any time of day, with or without food, due to its long half-life and active metabolites.
- Patients should be advised to report any unexplained muscle pain, tenderness, or weakness immediately.
- Avoid large quantities of grapefruit juice (>1.2 liters/day) due to potential for increased atorvastatin levels and risk of myopathy.
- Liver function tests are recommended at baseline and then as clinically indicated, rather than routine periodic monitoring, unless symptoms suggest liver injury.
- Atorvastatin is one of the most potent statins for LDL-C reduction.
- Consider drug interactions carefully, especially with strong CYP3A4 inhibitors, fibrates, and niacin, due to increased risk of myopathy.
Alternative Therapies
- Other HMG-CoA reductase inhibitors (Statins): Rosuvastatin, Simvastatin, Pravastatin, Lovastatin, Fluvastatin, Pitavastatin.
- PCSK9 inhibitors: Alirocumab, Evolocumab (for severe hypercholesterolemia, often in combination with statins).
- Ezetimibe (cholesterol absorption inhibitor).
- Bile acid sequestrants: Cholestyramine, Colesevelam, Colestipol.
- Fibrates: Fenofibrate, Gemfibrozil (primarily for hypertriglyceridemia).
- Niacin (Nicotinic Acid).
- Omega-3 fatty acid ethyl esters (for severe hypertriglyceridemia).